HERON THERAPEUTICS, INC.HRTX

Market cap

$303.15M

P/E ratio

	Dec 31, 2011	Dec 31, 2012	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022
Net product sales	-	-	-	-	-	-	-	77	146	89	86	108
Cost of product sales	-	-	-	-	-	-	-	28	62	36	46	55
Research and development	8	15	33	55	61	103	139	140	167	175	131	108
General and administrative	4	9	22	20	36	21	26	29	38	42	40	37
Sales and marketing	-	-	-	-	-	48	57	65	90	64	87	83
Total operating expenses	-	-	-	-	-	-	-	-	357	317	304	282
Loss from operations	-11	-24	-54	-75	-96,925,000	-171	-195	-184	-211	-228	-218	-175
Interest income	-	-	-	-	-	-	1	6	7	4	0	2
Interest expense	-	-	-	1	958,000	3	4	3	1	2	2	2
Other income (expense)	-	-	-	-1	292,000	0	-0	2	0	-1	-1	-7
Total other expense, net	-	-	-	-2	-666,000	-2	-3	5	6	1	-3	-7
Net loss	-12	-23	-55	-76	-98	-173	-197	-179	-205	-227	-221	-182
Unrealized losses on short-term investments	-	-	-	-	-	0	0	-0	0	0	-0	-0
Comprehensive loss	-	-	-	-	-98	-173	-197	-179	-205	-227	-221	-182
Basic net loss per share	-	-	-	-	-	-	-	-	-	-	-	-1.67
Diluted net loss per share	-	-	-	-	-	-	-	-	-	-	-	-1.67